WESPAC Advisors, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1484540 ORINDA, CA

Position in GILD

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$287,044

-$726,036 QoQ

Shares Held

2,272

-68.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.34%

of 13F equity value

Holder Rank

#1,675

of 2,266 holders

Holding Since

Sep 2023

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

WESPAC Advisors, LLC holds $6,216,166 across 5 Drug Manufacturers - General names. GILD ranks #4 (4.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	27,798	$3,572,043
2	LLY	ELI LILLY & Co	1,168	$1,400,934
3	AMGN	Amgen Inc	2,087	$755,744
4	GILD	Gilead Sciences, Inc. This page	2,272	$287,044
5	GSK	GSK plc	3,823	$200,401

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$287,044	2,272	-68.7%	Shares	Sole	2026-08-10
2026-03-31	$1,013,080	7,269	+14.9%	Shares	Sole	2026-04-29
2025-12-31	$776,821	6,329	-33.3%	Shares	Sole	2026-01-14
2025-06-30	$1,052,710	9,495	+322.6%	Shares	Sole	2025-07-23
2025-03-31	$251,776	2,247	-22.1%	Shares	Sole	2025-05-01
2024-03-31	$211,326	2,885	-1.5%	Shares	Sole	2024-04-24
2023-12-31	$237,278	2,929	+0.0%	Shares	Sole	2024-01-26
2023-09-30	$219,424	2,928	—	Shares	Sole	2023-10-26
No filing history on record for this holder in this stock.